1. Targeting T cell plasticity in kidney and gut inflammation by pooled single-cell CRISPR screening.
- Author
-
Enk LUB, Hellmig M, Riecken K, Kilian C, Datlinger P, Jauch-Speer SL, Neben T, Sultana Z, Sivayoganathan V, Borchers A, Paust HJ, Zhao Y, Asada N, Liu S, Agalioti T, Pelczar P, Wiech T, Bock C, Huber TB, Huber S, Bonn S, Gagliani N, Fehse B, Panzer U, and Krebs CF
- Subjects
- Animals, Humans, Mice, Glomerulonephritis immunology, Glomerulonephritis genetics, Cell Plasticity immunology, Cell Plasticity genetics, Kidney immunology, Kidney pathology, Mice, Inbred C57BL, CRISPR-Cas Systems, Colitis immunology, Colitis genetics, Inflammation immunology, Inflammation genetics, Female, Male, Clustered Regularly Interspaced Short Palindromic Repeats immunology, Single-Cell Analysis, Th17 Cells immunology
- Abstract
Pro-inflammatory CD4
+ T cells are major drivers of autoimmune diseases, yet therapies modulating T cell phenotypes to promote an anti-inflammatory state are lacking. Here, we identify T helper 17 (TH 17) cell plasticity in the kidneys of patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis on the basis of single-cell (sc) T cell receptor analysis and scRNA velocity. To uncover molecules driving T cell polarization and plasticity, we established an in vivo pooled scCRISPR droplet sequencing (iCROP-seq) screen and applied it to mouse models of glomerulonephritis and colitis. CRISPR-based gene targeting in TH 17 cells could be ranked according to the resulting transcriptional perturbations, and polarization biases into T helper 1 (TH 1) and regulatory T cells could be quantified. Furthermore, we show that iCROP-seq can facilitate the identification of therapeutic targets by efficient functional stratification of genes and pathways in a disease- and tissue-specific manner. These findings uncover TH 17 to TH 1 cell plasticity in the human kidney in the context of renal autoimmunity.- Published
- 2024
- Full Text
- View/download PDF